Iprindole

Drug #1952

Iprindole is a tricyclic antidepressant that has actions and uses similar to those of AMITRIPTYLINE, but has only weak antimuscarinic and sedative effects.

← Previous drug Next drug →

Primary Characteristics

Molecular Weight: 284.4 · Non-proprietary name: Iprindole.

Pharmacokinetics

None recorded.

Indications

Iprindole is primarily indicated in conditions like Depression.

Iprindole is also indicated for secondary conditions like Obsessive-compulsive disorders.

Contraindications

Iprindole is contraindicated in conditions like Mania.

Dosage

None recorded.

Drug Interactions

1 interaction

Major5 interactions

Moderate9 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Iprindole in overdosage may give rise to further complications which include Coma , Ataxia , Heart failure .

The signs and symptoms that are produced after acute overdosage of Iprindole are Blurred vision, Urinary retention, Hypothermia, Hypoglycemia, Sweating , Hyperflexia , Tachycardia , Convulsions .

Iprindole is known to cause more or less tolerable side effects which are usually transient. These include Constipation , Convulsions , Drowsiness, Dry mouth, Nausea, Rashes , Tremor, Weight gain.

Warnings / Precautions

IPRINDOLE posesses antimuscarinic activity so care should be taken in glaucoma and prostatic enlargement. Prolonged seizures have occurred following concurrent ECT. Avoid abrupt withdrawal. Withdraw IPRINDOLE gradually over several weeks. Caution in patients taking Monoamine Oxidase Inhibiting antidepressants (MAOI). IPRINDOLE may cause hypertensive crisis.

Available Brands

None recorded.

Drug Classification

1.24.2.1 — Drugs used in depression